We measure your sucsess

A new scientific publication involving Exacte Labs

We invite you to read the scientific article about the Phase I clinical trial of Angipur, co-authored by Vasiliy Kazey, CEO of Exacte Labs. The scientific publication was published in the journal «Cardiovascular Therapy and Prevention».


Results of a clinical study on safety, pharmacokinetics and pharmacodynamics of an original antiplatelet drug from the group of glycoproteins IIb/IIIa-receptor inhibitors in healthy volunteers

Fitilyov S.B., Glukhov Yu.F., Lukyanov S.V., Vozzhaev A.V., Shkrebneva I.I., Kazey V.I., Bondareva I.B.


The full text of the publication can be found here.

11 april 2022